Quantitative proteome profiling provides evidence of an activation of the complement cascade in ATTR amyloidosis. (3rd April 2022)

• Record Type: Journal Article
• Authors: Treitz, Christian; Gottwald, Juliane; Gericke, Eva; Urban, Peter; Meliß, Rolf Rüdiger; Axmann, Hans-Detlef; Siebert, Frank; Becker, Karsten; Tholey, Andreas; Röcken, Christoph
• Is Part Of: Amyloid. Volume 29:Number 2(2022)
• Page Start: 102
• Page End: 109
• Publication Date: 2022-04-03
• Subjects: Carpal tunnel syndrome -- ATTR amyloid -- LC-MS/MS -- complement system; Amyloidosis -- Periodicals; 616.3995
• DOI: 10.1080/13506129.2021.2015316
• Languages: English
• ISSNs: 1350-6129

Abstract

Abstract: Amyloidosis is a disease group caused by pathological aggregation and deposition of peptides in diverse tissue sites. Apart from the fibril protein, amyloid deposits frequently enclose non-fibrillar constituents. In this study, carpal tunnel tissue sections with ATTR amyloid were analysed by quantitative mass spectrometry-based proteomics. Following manual dissection, tissue samples of equal size and with heterogeneous amyloid load were dissected and forwarded to bottom-up proteome analysis and label-free protein profiling. The amyloid-associated proteins showed significant correlations of label-free intensity profiles. A comprehensive list of 83 proteins specifically enriched in amyloid deposits was discovered. In addition to well-known signature proteins (e.g. apolipoprotein E, apolipoprotein A-IV, and vitronectin), 22 members of the complement system, including all seven components of the membrane attack complex could be associated to the disease. These data lend support to the hypothesis that the complement system is activated in ATTR amyloidosis.